ArticleMolecular biomedicine2026

The DCBLD2 super-enhancer drives colorectal cancer progression through FOSL2/JUND-mediated activation of the CD146/AKT/TNFRSF6B pathway.

Tong Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.